xymbio, LLC

YOUR CORONAVIRUS RESOURCE
COVID-19
COVID-19
COVID-19
We Offer qPCR, CLIA Accredited COVID-19 Testing NOW
Radically Changing Infectious Disease Care for Our Partners
Infectious Disease Care
Infectious Disease Care
Rapid Results

Industry leading testing turnaround times to accelerate patient recovery.

Infectious Disease Care
Molecular Diagnosis

Ability to identify pathogenic genotype with the highest sensitivity and specificity.

Infectious Disease Care
Antimicrobial Resistance

Identification of resistance genes can rapidly improve treatment and outcomes paradigms.

Infectious Disease Care
Comprehensive Panels

Easily identify complicated infections with multiple pathogenic and non-pathogenic micro-organisms.

Infectious Disease Care
Antimicrobial Stewardship

Rapid test results and highly precise diagnosis allows accurate targeting of ID with proper antibiotic or antimicrobial.

Infectious Disease Care
Actionable Information

Receive ID diagnosis and treatment plan including region specific data to help guide clinical decisions.

Infectious Disease Care
Eliminate Trial and Error

Reduce or perhaps eliminate trial and error diagnosis and medication or loss of valuable time in patient care.

Infectious Disease Care
Complex Biofilm Samples

More easily identify complex multi pathogenic and mixed biofilm samples.

Infectious Disease Care
Extreme Sensitivity and Specificity

Identification of resistance genes rapidly changes treatment and outcome paradigm.

The BUG BOX ©
Patient Specimen Collection Kit

INFECTIOUS DISEASE

RISK

U.S. RISK OF ANTIMICROBIAL RESISTANCE

23,000

U.S. Yearly Infectious Disease Deaths (CDC)

2,000,000

Antimicrobial-Resistant Infections (CDC)

30%

Unnecessary Antibiotics Prescribed (CDC)

INFECTIOUS DISEASE

COST

U.S. COST OF ANTIMICROBIAL RESISTANCE

20

Billion $ Healthcare Spend (CDC)

35

Billion $ Lost Productivity (CDC)

10,960

Additional Days – Prolonged & Costlier Care (CDC)

8

Million Additional Hospital Days Spent (CDC)